Skip to content

Clinical trials

Phase 1/2 Hepatitis B, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Phase 1/2 Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20071
20081
20093
20111
20122
20132
20142
20152
20171
20181
20191
20201
20222
20234
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated4
Unknown status4
Recruiting3
Not yet recruiting3
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ausper Biopharma Co., Ltd.2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
GlaxoSmithKline2
Replicor Inc.2
Third Affiliated Hospital, Sun Yat-Sen University2
Vir Biotechnology, Inc.2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Aribio Lab Co., Ltd.1
Assembly Biosciences1
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic33
Hepatitis B7
Bronchiolitis Obliterans Syndrome2
Hepatitis2
Hepatitis, Chronic2
Liver Diseases1
Virus Diseases1

Trials

Showing 76 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.